David Petillo
Overview
Explore the profile of David Petillo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
2277
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Laskar R, Muller D, Li P, Machiela M, Ye Y, Gaborieau V, et al.
Eur J Hum Genet
. 2019 Jun;
27(10):1589-1598.
PMID: 31231134
Renal cell carcinoma (RCC) has an undisputed genetic component and a stable 2:1 male to female sex ratio in its incidence across populations, suggesting possible sexual dimorphism in its genetic...
2.
Johansson M, Carreras-Torres R, Scelo G, Purdue M, Mariosa D, Muller D, et al.
PLoS Med
. 2019 Jan;
16(1):e1002724.
PMID: 30605491
Background: Several obesity-related factors have been associated with renal cell carcinoma (RCC), but it is unclear which individual factors directly influence risk. We addressed this question using genetic markers as...
3.
Machiela M, Hofmann J, Carreras-Torres R, Brown K, Johansson M, Wang Z, et al.
Eur Urol
. 2018 Jun;
74(3):e85-e86.
PMID: 29853305
No abstract available.
4.
Machiela M, Hofmann J, Carreras-Torres R, Brown K, Johansson M, Wang Z, et al.
Eur Urol
. 2017 Aug;
72(5):747-754.
PMID: 28797570
Background: Relative telomere length in peripheral blood leukocytes has been evaluated as a potential biomarker for renal cell carcinoma (RCC) risk in several studies, with conflicting findings. Objective: We performed...
5.
Scelo G, Purdue M, Brown K, Johansson M, Wang Z, Eckel-Passow J, et al.
Nat Commun
. 2017 Jun;
8:15724.
PMID: 28598434
Previous genome-wide association studies (GWAS) have identified six risk loci for renal cell carcinoma (RCC). We conducted a meta-analysis of two new scans of 5,198 cases and 7,331 controls together...
6.
Gao C, Su Y, Koeman J, Haak E, Dykema K, Essenberg C, et al.
Proc Natl Acad Sci U S A
. 2016 Dec;
113(51):14793-14798.
PMID: 27930335
Chromosome instability (CIN) is the most striking feature of human cancers. However, how CIN drives tumor progression to metastasis remains elusive. Here we studied the role of chromosome content changes...
7.
Chen J, Huang D, Rubera I, Futami K, Wang P, Zickert P, et al.
Kidney Int
. 2015 Jun;
88(5):1057-69.
PMID: 26083655
The study of kidney cancer pathogenesis and its treatment has been limited by the scarcity of genetically defined animal models. The FLCN gene that codes for the protein folliculin, mutated...
8.
Kaneko-Tarui T, Commandeur A, Patterson A, DeKuiper J, Petillo D, Styer A, et al.
Mol Hum Reprod
. 2014 Sep;
20(11):1126-34.
PMID: 25189766
Uterine leiomyomata are the most common tumors found in the female reproductive tract. Despite the high prevalence and associated morbidities of these benign tumors, little is known about the molecular...
9.
Hansel D, Zhang Z, Petillo D, Teh B
BMC Med Genomics
. 2013 Oct;
6:42.
PMID: 24134934
Background: Bladder cancer exists as several distinct subtypes, including urothelial carcinoma (UCa), squamous cell carcinoma (SCCa), adenocarcinoma and small cell carcinoma. These entities, despite showing distinct morphology and clinical behavior,...
10.
Liu R, Dong Z, Liu J, Zhou L, Huang W, Khoo S, et al.
Mol Cancer Ther
. 2013 Aug;
12(10):2157-66.
PMID: 23956056
Platinum-based concurrent chemoradiotherapy is considered a standard treatment approach for locoregionally advanced nasopharyngeal carcinoma. However, only a minority of patients benefit from this treatment regimen compared with radiotherapy alone. Identification...